Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rank in Stocks #2084
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Share Price
$142.84
Last synced: 2026-10-20
Market Cap
$9.91B
Change (1 day)
0.62%
Change (1 year)
-56.58%
Country
US
Trade Insulet Corp. (PODD)

Category

Healthcare
Stock price history for Insulet Corp. (PODD)
Highest end of day price: $136.68 on 2026-10-01

Lowest end of day price: $15.32 on 2007-05-01
Stock price history of Insulet Corp. from 2007 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -28.52%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$102.70 -19.48%
US
$94.59 -1.30%
IE
$304.72 -19.76%
US
$45.61 -54.34%
US
$49.15 -12.81%
DE